Quote:When looking into dostarlimab, I was surprised to see that it was approved for "any dMMR/MSI-H positive solid tumor." I'd always thought that it typically takes Phase 3 trials in specific indications to approve a cancer therapeutic. I was wrong!
Apparently the case for pembro as well. Dr. PSS of ImmunityBio has been trying to use this as justification for wide approval of his anktiva.
https://x.com/DrPatrick/status/2022009584723128651